Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Drug Evaluation Research》 2011-05
Add to Favorite Get Latest Update

Request for peer review on toxicological pathology

KONG Qing-xi,YAO Quan-sheng, HUANG Yi-yi,LI Rong-rong,LI Man,LV Juan,YANG Ran Tripod Preclinical Research Laboratories, Nanjing 211800, China  
The aim of peer review on toxicological pathology is to verify and improve the accuracy and quality of pathology diagnoses and data interpretations.The peer review on toxicological pathology is commonly performed before a study report completed.The peer review pathologist will review enough biopsys and pathological data to assist the study pathologist in refining pathology diagnoses and data interpretations.Data supplied by the study pathologist are to be reviewed and selected by the peer review pathologist.The consultations with the additional experts or a pathological panel may be used to resolve discrepancies if necessary.The study pathologist is solely responsible for the content of the final pathological data and reports, modifies the results according to the peer review discussions,and signs the final pathologists report.The peer review pathologist should give a signed peer review report with describing the peer review process and confirming that the study pathologist’s report could accurately and appropriately reflect the pathology data.The study pathologist also needs to check back and sign his or her name on the peer review report,which is proved to agree with the peer review pathologist.The types and modes currently implemented by the peer review on toxicological pathology should be recommended and may be modified to meet the demand of a specific study.
【CateGory Index】: R95
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
Chinese Journal Full-text Database 1 Hits
1 WANG Jia-nan, CAO Cai Center for Certification of Drug, State Food and Drug Administration, Beijing 100061, China;Standardization of pathology work in GLP facility[J];Drug Evaluation Research;2011-04
【Secondary Citations】
Chinese Journal Full-text Database 6 Hits
1 WANG Shao-yan,LI Li,LI Yan(Drug Safety Evalution of Shandong Institute of Pharmaceutical Industry,Ji′nan 250033);Pathological evaluation of drug safety and technical personnel in personal protective[J];Qilu Pharmaceutical Affairs;2010-04
2 LU Jian-jun,LI Bo(National Center for Safety Evaluation of Drugs,National Institute for the Control of Pharmaceutical and Biological Products,Beijing 100176,China);Applications of the new technologies of toxicologic pathology in the field of preclinical safety evaluation of drugs[J];Chinese Journal of Pharmaceutical Analysis;2010-07
3 CHENG Shu-jun~1,HUANG Ren~2(1.Guangdong Entry-Exit Inspection and Quarantine Technology Center,GuangZhou 510623,China;2.Guangdong Laboratory Animal Monitoring Institute,GuangZhou 510260,China);The Existing Problem and Countermeasure of Toxicity Pathology in GLP Medicine Safety Evaluation[J];Chinese Journal of Comparative Medicine;2007-01
4 HAN Tie, WU Chun-qi, LIAO Ming-yang (Institute of Toxicology and Pharmacology, Academy of Military Medical Science, Beijing 100850, China);Quality assurance of toxic pathological evaluations[J];Chinese Journal of New Drugs;2006-06
5 ZHANG Liang1,LI Bo2(1 SuZhou PharmaTech Co.,Ltd.,Suzhou 215111,China;2 National Center for Safety Evaluation of Drugs,National Institute for the Control of Pharmaceutical and Biological Products,Beijing 100176,China);Best GLP standards for the pathological reports of toxicology[J];Chinese Journal of New Drugs;2008-02
6 LI Shan-shan,LI Bo,WANG Jun-zhi(National Institute for the Control of Pharmaceatical & Biological Products,P.R.China,Beijing 100176,China);Concise elucidation of the toxicologic pathology[J];Chinese Journal of New Drugs;2008-06
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved